{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Apollo Hospitals Enterprise Ltd.
Apollo Hospitals Sees Sharp Open Interest Surge Amid Bearish Price Action
Apollo Hospitals Enterprise Ltd. has witnessed a significant 14.03% rise in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with declining prices and subdued investor participation, suggests a complex positioning landscape with potential directional bets emerging among traders.
Apollo Hospitals Sees Sharp Open Interest Surge Amidst Weak Price Performance
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has witnessed a notable 12.13% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with declining prices and subdued investor participation, suggests a complex interplay of directional bets and market positioning that investors should carefully analyse.
Apollo Hospitals Sees Sharp Open Interest Surge Amidst Weak Price Action
Apollo Hospitals Enterprise Ltd. has witnessed a notable 10.6% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with declining prices and volume patterns, suggests a shift in market positioning that may indicate growing bearish sentiment among traders.
P/E at 59.54 vs Industry's 54.79: What the Data Shows for Apollo Hospitals Enterprise Ltd.
A price-to-earnings ratio of 59.54 against an industry average of 54.79 represents a notable premium for Apollo Hospitals Enterprise Ltd. Previously rated Buy by MarketsMOJO, the company’s rating was reassessed to Hold on 9 January 2026. While the one-year return of 13.26% comfortably outpaces the Sensex’s decline of 2.98%, the shorter-term performance reveals a more nuanced picture with mixed momentum across various timeframes.
Apollo Hospitals Enterprise Ltd. is Rated Hold
Apollo Hospitals Enterprise Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
P/E at 59.76 vs Industry's 55.44: What the Data Shows for Apollo Hospitals Enterprise Ltd.
Apollo Hospitals Enterprise Ltd, a stalwart in India’s hospital sector and a prominent Nifty 50 constituent, has recently experienced notable shifts in its market performance and institutional holdings. Despite a modest decline in the short term, the company’s long-term trajectory remains robust, underscoring the significance of its benchmark index membership and evolving investor sentiment.
Apollo Hospitals Declines 2.47% Amid Valuation Shift and Market Pressure
Apollo Hospitals Enterprise Ltd. closed the week down 2.47% at Rs.7,363.20, underperforming the Sensex which fell 0.28% over the same period. The stock faced valuation headwinds and technical pressure amid broader market volatility, with notable intraday lows and a downgrade in sentiment. Despite these challenges, Apollo’s long-term performance remains robust relative to the benchmark.
Apollo Hospitals Gains 2.52%: 4 Key Factors Driving This Week’s Momentum
Apollo Hospitals Enterprise Ltd. recorded a 2.52% gain over the week ending 27 March 2026, closing at Rs.7,548.40, outperforming the Sensex which declined 1.46% during the same period. The stock experienced notable volatility, with a sharp decline on 23 March followed by two consecutive days of strong recovery supported by rising open interest in derivatives. This review analyses the key events shaping the stock’s performance and the broader market context.
P/E at 60.15 vs Industry's 56.45: What the Data Shows for Apollo Hospitals Enterprise Ltd.
A price-to-earnings ratio of 60.15 against an industry average of 56.45 marks a notable premium for Apollo Hospitals Enterprise Ltd. Previously rated Buy by MarketsMOJO, the stock’s rating has been reassessed. While the one-year return comfortably outpaces the Sensex, the shorter-term momentum reveals a more nuanced picture, highlighting a divergence in performance across timeframes.
Apollo Hospitals Sees Sharp Open Interest Surge Amid Rising Market Momentum
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock’s recent price gains, coupled with increased volume and open interest, suggest evolving directional bets among traders in the hospital sector.
Apollo Hospitals Sees Sharp Open Interest Surge Amid Rising Market Momentum
Apollo Hospitals Enterprise Ltd. has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and evolving investor positioning. This development coincides with the stock’s recent upward momentum, reflecting a complex interplay of directional bets and liquidity dynamics within the hospital sector.
Apollo Hospitals Sees Sharp Open Interest Surge Amid Rising Market Momentum
Apollo Hospitals Enterprise Ltd. has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes alongside a steady price appreciation and increased trading volumes, reflecting growing confidence in the hospital sector amid broader market gains.
Apollo Hospitals Sees Significant Open Interest Surge Amid Rising Market Momentum
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and shifting investor positioning, offers valuable insights into the evolving sentiment within the hospital sector and broader market dynamics.
P/E at 58.8 vs Industry's 55.3: What the Data Shows for Apollo Hospitals Enterprise Ltd.
A price-to-earnings ratio of 58.8 against an industry average of 55.3 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Buy by MarketsMOJO, the stock’s rating was reassessed on 09 Jan 2026. While the one-year return of 13.18% comfortably outpaces the Sensex’s decline of 4.14%, the three-month performance tells a different story with a more moderate 4.79% gain versus the Sensex’s sharper 12.43% fall. This divergence highlights shifting momentum within varying timeframes.
Apollo Hospitals Sees Sharp Open Interest Surge Amid Bullish Market Momentum
Apollo Hospitals Enterprise Ltd. witnessed a notable surge in open interest in its derivatives segment on 24 Mar 2026, signalling increased market participation and potential directional bets. The stock outperformed its sector and broader indices, reflecting growing investor confidence amid evolving market dynamics.
Apollo Hospitals Enterprise Ltd. Rallies 3.1% and Approaches Key Moving Averages Amid Mixed Market Sentiment
The Sensex slipped 1.05% on 24 Mar 2026, while Apollo Hospitals Enterprise Ltd. surged 3.1%, outperforming its sector by 1.44 percentage points. This notable single-session gain stands out as a stock-specific event in a broadly weak market environment.
P/E at 56.44 vs Industry's 54.03: What the Data Shows for Apollo Hospitals Enterprise Ltd.
Apollo Hospitals Enterprise Ltd, a stalwart in India’s hospital sector and a prominent Nifty 50 constituent, continues to demonstrate resilience amid evolving market conditions. Despite a recent downgrade in its Mojo Grade to 'Hold' from 'Buy', the company’s robust long-term performance and significant institutional interest underscore its pivotal role within the benchmark index and the broader healthcare industry.
Apollo Hospitals Enterprise Ltd. Hits Intraday Low Amid Price Pressure
Apollo Hospitals Enterprise Ltd. experienced a notable decline on 23 Mar 2026, touching an intraday low of Rs 7,100, down 3.57% from previous levels, reflecting significant price pressure in line with sector trends and broader market weakness.
P/E at 58.15 vs Industry's 55.37: What the Data Shows for Apollo Hospitals Enterprise Ltd.
Apollo Hospitals Enterprise Ltd, a stalwart in India’s hospital sector and a prominent Nifty 50 constituent, has recently experienced notable shifts in its market performance and institutional holdings. Despite a modest decline in daily trading, the company’s long-term trajectory remains robust, underscoring its significance within the benchmark index and the broader healthcare industry.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
